Pressure BioSciences (PBI) has secured CE mark approval for its next-generation PCT-based sample preparation instrument, Barocycler 2320EXTREME.
The approval allows the company to market Barocycler next-generation sample preparation instrument in the European Economic Area (EEA).
Compared to earlier Barocycler models, the new instrument has additional features such as data logging options, user-level security, computer-operated control with touch screen programming, and the ability to customize multiple pressure cycling parameters.
Life science key opinion leaders can use the new instrument in the preparation of protein samples for analysis.
PBI marketing and sales vice president Dr Nate Lawrence said: "Achievement of CE Marking for the Barocycler 2320EXT is an important next step in our commercialization plans for this powerful and enabling sample preparation instrument, especially since CE Marking is required prior to selling the Barocycler 2320EXT to the large and potentially lucrative biopharmaceutical market in Europe.
“We recently signed agreements with several strong distribution partners in Europe, our SCIEX co-marketing agreement is entering its second year (SCIEX is a global provider of laboratory instrumentation to the life sciences area, with a large presence in Europe), and Professor Ruedi Aebersold – one of the most recognized world leaders in proteomics – recently purchased two Barocycler 2320EXTs.”
Pressure BioSciences develops and produces laboratory instrumentation and associated consumables for the life sciences sample preparation market.
The company also produces products for the drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development, histology and forensic applications.